[Efficacy of danazol in the treatment of thrombopenia in a chronic HIV-seropositive hemodialyzed patient. Unexpected appearance of major hyperglycemia].
Morinière
P
P
Service de Néphrologie-Hémodialyse, CHU Amiens, Sud.
Gross
S
S
Lalau
J D
JD
Schmit
J L
JL
Westeel
P F
PF
Ruiz
J C
JC
Claisse
J F
JF
Andrejak
M
M
Fournier
A
A
D000328:Adult; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use*; D005989:Glycerides / Q000097:blood*; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008297:Male; D011245:Pregnadienes / Q000627:therapeutic use*; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000150:complications / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D005989:Glycerides; D011245:Pregnadienes; D014409:Tumor Necrosis Factor-alpha; D003613:Danazol
Efficacité du danazol dans le traitement de la thrombopénie d'un hémodialysé chronique VIH séropositif. Survenue d'une hyperglycéridémie majeure.